The Effect of Coenzyme Q10 on Hearing and Tinnitus Characteristics of Chronic Tinnitus Patients
NCT ID: NCT02353650
Last Updated: 2016-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
INTERVENTIONAL
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Modulating Mechanisms in Patients With Chronic Subjective Tinnitus and/or Chronic Pain
NCT05186259
Randomized Trial Of Tinnitus Retraining Therapy
NCT00578058
Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.
NCT05292534
Internet-based Guided Self-help for Chronic Tinnitus
NCT01205919
Clinical Trial of Sound-Based Versus Behavioral Therapy for Tinnitus
NCT03022084
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
TREATMENT
QUADRUPLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Q10
placebo
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* tinnitus has a clear otological cause
* age \> 18 years
Exclusion Criteria
* persons who take already Q10
* pregnancy
* cervical tinnitus
* holocranial tinnitus
* depression
* mental of neurological disorders
* history of chemotherapy
* middle ear diseases
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Antwerp
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ethisch Comité UZA
Ethics Committee
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital of Antwerp
Edegem, Antwerp, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14/27/286
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.